TY - JOUR
T1 - La tomografia con emissione di positroni (PET) con F-18 FDG nello studio delle formazioni espansive con sede surrenalica
T2 - Confronto tra lesioni benigne e maligne
AU - Maurea, Simone
AU - Mainolfi, Ciro
AU - Wang, Hui
AU - Varrella, Paola
AU - Panico, Maria Rosaria
AU - Klain, Michele
AU - Rossi, Riccardo
AU - Cremona, Francesco
AU - Bazzicalupo, Lucio
AU - Salvatore, Marco
PY - 1996/12
Y1 - 1996/12
N2 - In this study, 15 patients (4 men and 11 women, mean age: 50 ± 13 years) with unilateral adrenal masses detected on ultrasound (US), Computed Tomography (CT) and/or Magnetic Resonance (MR) studies were submitted to positron emission tomography (PET) with fluorine-18 deoxyglucose (FDG). Histology demonstrated 3 adenomas, 1 myelolipoma, 1 angiolipoma, 1 neurinoma, 1 cyst, 1 malignant pheochromocytoma, 4 carcinomas and 3 metastases. The patient population was divided into two groups. Group 1 (n = 7) consisted of benign adrenal lesions. Group 2 consisted of malignant adrenal tumors. Lesion measurements were performed on the basis of the results of US, CT and/or MR images. In Group 1, no FDG uptake was observed in adrenal masses. Conversely, in Group 2 adrenal lesions showed abnormally increased FDG uptake, suggesting high glucose tumor metabolism. No significant difference in lesion size was observed between Groups 1 and 2 (5.6 ± 4.0 vs 6.3 ± 3.0 cm). Furthermore, in 6 patients of Group 2, total body PET images showed abnormal FDG uptake in extra-adrenal locations, such as chest (n = 2) and abdominal (n = 5) lymph nodes, lungs (n = 6), liver (n = 5), pancreas (n = 1), bone (n = 1) and muscle (n = 1) tissues. In conclusion, the results of this study suggest that PET imaging with FDG can characterize adrenal masses. In particular, abnormally increased FDG uptake in adrenal malignancies allows to differentiate these abnormalities from benign lesions. Furthermore, total body imaging PET can identify extra-adrenal tumor sites in patients with malignant tumors.
AB - In this study, 15 patients (4 men and 11 women, mean age: 50 ± 13 years) with unilateral adrenal masses detected on ultrasound (US), Computed Tomography (CT) and/or Magnetic Resonance (MR) studies were submitted to positron emission tomography (PET) with fluorine-18 deoxyglucose (FDG). Histology demonstrated 3 adenomas, 1 myelolipoma, 1 angiolipoma, 1 neurinoma, 1 cyst, 1 malignant pheochromocytoma, 4 carcinomas and 3 metastases. The patient population was divided into two groups. Group 1 (n = 7) consisted of benign adrenal lesions. Group 2 consisted of malignant adrenal tumors. Lesion measurements were performed on the basis of the results of US, CT and/or MR images. In Group 1, no FDG uptake was observed in adrenal masses. Conversely, in Group 2 adrenal lesions showed abnormally increased FDG uptake, suggesting high glucose tumor metabolism. No significant difference in lesion size was observed between Groups 1 and 2 (5.6 ± 4.0 vs 6.3 ± 3.0 cm). Furthermore, in 6 patients of Group 2, total body PET images showed abnormal FDG uptake in extra-adrenal locations, such as chest (n = 2) and abdominal (n = 5) lymph nodes, lungs (n = 6), liver (n = 5), pancreas (n = 1), bone (n = 1) and muscle (n = 1) tissues. In conclusion, the results of this study suggest that PET imaging with FDG can characterize adrenal masses. In particular, abnormally increased FDG uptake in adrenal malignancies allows to differentiate these abnormalities from benign lesions. Furthermore, total body imaging PET can identify extra-adrenal tumor sites in patients with malignant tumors.
KW - adrenal gland, tumors
KW - adrenal tumors, F-18 FDG
KW - adrenal tumors, PET
UR - http://www.scopus.com/inward/record.url?scp=12644300661&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=12644300661&partnerID=8YFLogxK
M3 - Articolo
C2 - 9122472
AN - SCOPUS:12644300661
VL - 92
SP - 782
EP - 787
JO - Radiologia Medica
JF - Radiologia Medica
SN - 0033-8362
IS - 6
ER -